TRISPOLIS
ActiveSummary
TRISPOLIS has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €248,725 and a net result of €166,046. Equity has been growing by about 38% per year since 2022. Its solvency ranks better than 94% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 18-01-2022 Normal situation
- Activity
- Specialist medical practice NACE 86220
- Establishment units
- 2.327.461.748 1020 Brussel, since 18-01-2022
- 2.327.461.847 1070 Anderlecht, since 18-01-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 30-11-2025
Board and ownership
Board
- MAWLAWI HadiDirector
- WALRAVENS Christine Yveline Jean-PaulDirector
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €234,415
- ▼ 5.9%
- Turnover
- ≈ €440,000
- estimated
- Profit
- €166,046
- ▼ 6.3%
- Equity
- €248,725
- ▼ 33.7%
- Total assets
- €258,089
- ▼ 43.8%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 25.76, cash €173,174, halvedSize: total assets €258,089Equity €248,725 (96.4% of total assets)Show the evidence
Checked score
Score 2025
96
/ 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 68% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency
100=
equity 96.4% of total assets
Liquidity
100+5
short-term debt 3.6% · cash 67.1%
Profitability
100=
return on assets 64.3%
Bankruptcy probability within 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025highest value
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: < 0.1%● unchanged vs 08-2025
10-2025: < 0.1%● unchanged vs 09-2025
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €23,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 25.76 (5.16 in 2024), above the usual 1.5. Short-term debt is 3.6% and cash 67.1% of total assets. 3.6% of the assets are financed with debt and provisions.
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 80% on profitability and 17% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
1 day early
2024
6 days early
2023
30 days late
2022
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 4 accounts on average 14 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 15 August (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 30-07-2026 at the NBB all 4 filings
Turnover
≈ €440,000
Estimated: probably between €370,000 and €570,000
Total assets
€258,089▼ 43.8%
2024 · €459,240
Net result
€166,046▼ 6.3%
2024 · €177,148
Working capital
€228,864▼ 33.1%
2024 · €341,996
Multi-year overview
2022 to 2025, 4 financial yearsOperating result
€217,150
▼ 6.4%
2025
20222025
Net result
€166,046
▼ 6.3%
2025
highest quarter of the sector
20222025
Equity
€248,725
▼ 33.7%
2025
middle half of the sector
20222025
Total assets
€258,089
▼ 43.8%
2025
middle half of the sector
20222025
Debt
€9,364
▼ 88.9%
2025
20222025
Working capital
€228,864
▼ 33.1%
2025
middle half of the sector
20222025
Solvency
96.4%
▲ 14.7pp
2025
highest quarter of the sector
20222025
Current ratio
25.76
▲ 20.60
2025
highest quarter of the sector
20222025
Return on assets (ROA)
64.3%
▲ 25.8pp
2025
highest quarter of the sector
20222025
Every figure per financial year
Every figure with its change against the financial year before
favourable
unfavourable
Line2022202320242025
Operating result€116,685-€151,498▲ 29.8%€232,097▲ 53.2%€217,150▼ 6.4%
Net result€82,179within the sector's middle half-€115,331above the sector's middle half▲ 40.3%€177,148above the sector's middle half▲ 53.6%€166,046above the sector's middle half▼ 6.3%
Equity€82,679within the sector's middle half-€198,010within the sector's middle half▲ 139%€375,158within the sector's middle half▲ 89.5%€248,725within the sector's middle half▼ 33.7%
Total assets€200,807within the sector's middle half-€285,577within the sector's middle half▲ 42.2%€459,240within the sector's middle half▲ 60.8%€258,089within the sector's middle half▼ 43.8%
Debt€118,128-€87,567▼ 25.9%€84,082▼ 4.0%€9,364▼ 88.9%
Working capital€63,436within the sector's middle half-€171,595within the sector's middle half▲ 171%€341,996above the sector's middle half▲ 99.3%€228,864within the sector's middle half▼ 33.1%
Solvency41.2%within the sector's middle half-69.3%within the sector's middle half▲ 28.2pp81.7%within the sector's middle half▲ 12.4pp96.4%above the sector's middle half▲ 14.7pp
Current ratio1.91within the sector's middle half-3.72within the sector's middle half▲ 1.815.16within the sector's middle half▲ 1.4425.76above the sector's middle half▲ 20.60
Return on assets (ROA)40.9%above the sector's middle half-40.4%above the sector's middle half▼ 0.5pp38.6%above the sector's middle half▼ 1.8pp64.3%above the sector's middle half▲ 25.8pp
above
within
below
The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.
The operating result for 2025 is 6% lower than in 2024.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €258,089
Fixed assets
€19,981 ▼ 43.0%
Current assets
€238,108 ▼ 43.9%
Equity and liabilities €258,089
Equity
€248,725 ▼ 33.7%
Debt
€9,364 ▼ 88.9%
Debt's share of the balance-sheet total falls from 18.3% to 3.6%. Equity and debt are lower.
Key figures and ratios
EBITDA
€234,168▼
2024 · €248,819
Cash flow
€183,064▼
2024 · €193,871
Debt to equity
0.04▼
2024 · 0.22
ROE
66.8%▲
2024 · 47.2%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€9,244▼
2024 · €82,182
Income taxes
€51,895▼
2024 · €54,658
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Investments
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Tangible fixed assets | €82,859 | - | €799 | €1,936 |
| Financial fixed assets | €270 | - | - | - |
| Depreciation and write-downs of the year | €15,302 | €16,697 | €16,723 | €17,018 |
Source: notes to the 2022 to 2025 annual accounts (statement of fixed assets)
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €15,302 | €16,697 | €16,723 | €17,018 | ▲ 1.8% |
| Other operating charges640/8 | €4,679 | €202 | €298 | €248 | ▼ 16.9% |
| Gross operating margin9900 | €136,666 | €168,397 | €249,118 | €234,415 | ▼ 5.9% |
| Operating profit (loss)9901 | €116,685 | €151,498 | €232,097 | €217,150 | ▼ 6.4% |
| Financial income75/76B | - | - | €236 | €1,138 | ▲ 382% |
| Recurring financial income75 | - | - | €236 | €1,138 | ▲ 382% |
| Financial charges65/66B | €1,011 | €759 | €527 | €347 | ▼ 34.2% |
| Recurring financial charges65 | €1,011 | €759 | €527 | €347 | ▼ 34.2% |
| Profit (loss) for the period before taxes9903 | €115,675 | €150,738 | €231,806 | €217,941 | ▼ 6.0% |
| Income taxes67/77 | €33,496 | €35,408 | €54,658 | €51,895 | ▼ 5.1% |
| Profit (loss) for the period9904 | €82,179 | €115,331 | €177,148 | €166,046 | ▼ 6.3% |
| Profit (loss) for the period to be appropriated9905 | €82,179 | €115,331 | €177,148 | €166,046 | ▼ 6.3% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €200,807 | €285,577 | €459,240 | €258,089 | ▼ 43.8% |
| Fixed assets21/28 | €67,828 | €50,986 | €35,062 | €19,981 | ▼ 43.0% |
| Tangible fixed assets22/27 | €67,558 | €50,861 | €34,937 | €19,856 | ▼ 43.2% |
| Furniture and vehicles24 | €67,558 | €50,861 | €34,937 | €19,856 | ▼ 43.2% |
| Financial fixed assets28 | €270 | €125 | €125 | €125 | = |
| Current assets29/58 | €132,980 | €234,592 | €424,178 | €238,108 | ▼ 43.9% |
| Amounts receivable within one year40/41 | €45,003 | €49,673 | €60,334 | €56,108 | ▼ 7.0% |
| Trade receivables40 | €44,123 | €48,273 | €55,896 | €53,302 | ▼ 4.6% |
| Other amounts receivable41 | €880 | €1,399 | €4,438 | €2,805 | ▼ 36.8% |
| Cash at bank and in hand54/58 | €82,534 | €178,587 | €357,444 | €173,174 | ▼ 51.6% |
| Deferred charges and accrued income490/1 | €5,443 | €6,332 | €6,401 | €8,827 | ▲ 37.9% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €200,807 | €285,577 | €459,240 | €258,089 | ▼ 43.8% |
| Equity10/15 | €82,679 | €198,010 | €375,158 | €248,725 | ▼ 33.7% |
| Contributions10/11 | €500 | €500 | €500 | €500 | = |
| Reserves13 | €82,179 | €82,179 | €82,179 | €82,179 | = |
| Distributable reserves133 | €82,179 | €82,179 | €82,179 | €82,179 | = |
| Profit (loss) carried forward14 | - | €115,331 | €292,479 | €166,046 | ▼ 43.2% |
| Amounts payable17/49 | €118,128 | €87,567 | €84,082 | €9,364 | ▼ 88.9% |
| Amounts payable after more than one year17 | €47,006 | €24,571 | €1,900 | - | - |
| Financial debts170/4 | €47,006 | €24,571 | €1,900 | - | - |
| Amounts payable within one year42/48 | €69,544 | €62,997 | €82,182 | €9,244 | ▼ 88.8% |
| Current portion of amounts payable after more than one year42 | €22,202 | €22,435 | €22,671 | €1,900 | ▼ 91.6% |
| Trade debts44 | €9,066 | €2,748 | €2,419 | €2,937 | ▲ 21.4% |
| Suppliers440/4 | €9,066 | €2,748 | €2,419 | €2,937 | ▲ 21.4% |
| Taxes, remuneration and social security45 | €38,275 | €37,814 | €57,092 | €4,406 | ▼ 92.3% |
| Taxes450/3 | €38,275 | €37,814 | €57,092 | €4,406 | ▼ 92.3% |
| Accrued charges and deferred income492/3 | €1,579 | - | - | €120 | - |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €82,179 | €115,331 | €177,148 | €166,046 | ▼ 6.3% |
| + Depreciation and write-downs630 | €15,302 | €16,697 | €16,723 | €17,018 | ▲ 1.8% |
| Operating cash flow (approximation) | €97,481 | €132,028 | €193,871 | €183,064 | ▼ 5.6% |
| Investment in fixed assets (approximation) | - | €145 | -€799 | -€1,936 | ▼ 142% |
| Change in cash | - | €96,053 | €178,857 | -€184,270 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 39,278 companies had the same profile as TRISPOLIS has now. Two years later, 95.8% were still going and 1.8% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
95.8%
was still going
2.3%
stopped otherwise
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of TRISPOLIS itself is lower: < 0.1% within 12 months. It rests on far more data about TRISPOLIS than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for TRISPOLIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Board & ownership
Directors
Directors
2 directors, no change since 2022
MAWLAWI Hadi
Current
Director · appointed in the act of 20-01-2022
WALRAVENS Christine Yveline Jean-Paul
Current
Director · appointed in the act of 20-01-2022
Owners and capital
Owners
Mandate history
2 people, 2 in office
- Board
| Name | Functions and periods |
|---|---|
| MAWLAWI Hadi |
|
| WALRAVENS Christine Yveline Jean-Paul |
|
Articles of association
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Articles of association, deed of 20-01-2022 (in French)
Network & group
TRISPOLIS shares no director with another company.
Companies at the same address
2 other companiesConnections & network
2 current directorsThe network starts from the directors of TRISPOLIS. Every other company they run is a node.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Timeline
Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
30-07
micro format · 1 day before the deadline
2025
31-12
Financial
Liquidity more than quadruplescurrent ratio 25.76
The current ratio rises from 5.16 to 25.76. Short-term debt falls from €82,182 to €9,244.
25-07
micro format · 6 days before the deadline
2024
31-12
Financial
Highest result from 2022 to 2025net €177,148 ▲53.6%
The operating result of €232,097 and the net result of €177,148 are both a record.
31-12
Financial
Equity above €200,000equity €375,158 ▲89.5%
With a profit in every financial year since 2022, equity grows to €375,158.
30-08
micro format · 30 days late
2023
31-12
Financial
Equity above €150,000equity €198,010 ▲139%
With a profit in every financial year since 2022, equity grows to €198,010.
31-08
micro format · 31 days late
2022
20-01
Gazette deed
IncorporationAppointments: MAWLAWI Hadi (director) and WALRAVENS Christine Yveline Jean-Paul (director) · Founding capital · Bank account10 points ▸
Gazette deed
Incorporation
Appointments: MAWLAWI Hadi (director) and WALRAVENS Christine Yveline Jean-Paul (director) · Founding capital · Bank account10 points ▸
- Incorporation, 17-01-2022
- Founding capital, €500
- Bank account, “BNP PARIBAS FORTIS, société en formation” (deed in French)
- Other provision, “attestation de dépôt des fonds, attestation justifiant ce dépôt” (deed in French)
- Other provision, “identité des fondateurs non reprise dans l'extrait, capitaux propres de départ entièrement libérés” (deed in French)
- Capital
- Registered office clause, “1090 Jette, Drève de Rivieren 210(boîte 10)” (deed in French)
- Director appointment, MAWLAWI Hadi (director)
- Director appointment, WALRAVENS Christine Yveline Jean-Paul (director)
- Other provision, “dossier de la société, dépôt statuts coordonnés” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordName
TRISPOLIS in French
Enterprise number
0780.580.279
Legal form
Private limited company
Status
Active, normale toestand
Founded
18-01-2022
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 20-01-2022 (in French)Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Région de Bruxelles-Capitale, par simple décision de l’organe d’administration,des sièges administratifs,tant en Belgique qu'à…”
deed of 20-01-2022 (in French)Registered office and establishments
Registered office
de Rivierendreef 210, 1090 Jette, Belgium
Establishment units
Romeinsesteenweg 801, 1020 Brussel since 18-01-2022 · unit number 2.327.461.748
Jules Graindorlaan 66, 1070 Anderlecht since 18-01-2022 · unit number 2.327.461.847
Activities
NACEBEL 202586220
Specialist medical practice main activity
Codes under NACEBEL 2008
86220
Human health activities main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
deed of 20-01-2022 (in French)
“Pratiquer une médecine de qualité par l’amélioration et la rationalisation de l’équipement professionnel notamment en assurant la gestion…”
10 activities
- Pratiquer une médecine de qualité par l’amélioration et la rationalisation de l’équipement professionnel notamment en assurant la gestion d’un cabinet médical,en ce compris l’acquisition,la location et l’entretien du matériel médical et des biens d’équipement,la facturation,et la perception d’honoraires médicaux,la mise à disposition de tout ce qui est nécessaire à l’exercice de l’art de guérir
- Organiser et animer des conférences,des séminaires,des colloques,des symposiums,des stages,des cours et des journées d’études,dans le cadre de ses activités pré-décrites
- Gérer un centre médical ou un cabinet médical,en ce compris l’acquisition,la location et l’entretien du matériel médical et des biens d’équipement,la facturation et la perception d’honoraires médicaux,la mise à disposition de tout ce qui est nécessaire à la pratique de guérir
- Faire tout acte nécessaire et/ou indispensable à l’accomplissement de son objet et plus particulièrement toute transaction mobilière et immobilière concernant les locaux médicaux,l’achat du matériel médical et non médical,l’engagement du personnel administratif,soignant,pratiquant ou appelé à pratiquer dans la société
- Louer ou sous louer,acquérir des droits réels ou la pleine propriété de tout immeuble dans le but soit d’y établir son siège,un siège d’activité ou d’y loger son dirigeant et les membres de sa famille à titre de résidence principale ou secondaire,tant en Belgique qu’à l’étranger
- Acquérir et prendre en concession tous droits de propriété intellectuelle en rapport direct avec ses activités médicales et les exploiter sous quelle que forme que ce soit pour son propre usage
- Gestion et la valorisation d’un patrimoine immobilier,avec ou sans lien direct avec ses autres activités,en pleine propriété ou en droits réels,notamment par l’achat,la vente,la location,la mise en location,la viabilisation,le lotissement,la mise à disposition,la rénovation,la construction,le tout au sens le plus large
- Hypothéquer et affecter en garantie tous biens meubles ou immeubles pour son compte propre ou pour le compte de son dirigeant,et/ou réaliser toute opération d’engagement à titre de caution,aval ou garanties quelconques pour le compte de son dirigeant
- S’intéresser par voie d’apport,de fusion,de scission,de participation,de souscription et/ou par toutes autres voies dans toutes sociétés,entreprises ou associations existantes ou à créer,dont l’objet est similaire ou connexe,en tout ou en partie,au sien,ou de nature à favoriser la réalisation ou le développement de son objet
- Être gérante ou liquidateur de sociétés dont l’objet est analogue ou connexe au sien,pour les affaires non médicales uniquement
Invoicing and payment
VAT number
BE 0780.580.279
Financial year and general meeting
Accounts at the NBBFinancial year end
31-12
Sites & property
Location
Buildings and parcels at the addresses
Ground area
1.9 ha
Building footprint
4,739 m²
Building volume
91,182 m³
Tallest building: 36.1 m.
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21304B0056/00W000 | Brussels | 1.7 ha | 1 · 4,271 m² | 36.0 m · 5 |
| 21463C0430/00N002 | Brussels | 963 m² | 1 · 294 m² | 19.4 m · 5 |
| 21816G0043/00T002 | Brussels | 952 m² | 1 · 173 m² | 12.2 m · 3 |